VERDICT -II TCA, VERDICT-II MTD

Radioimmunoassay, Tricyclic Antidepressant Drugs

MEDTOX DIAGNOSTICS, INC.

The following data is part of a premarket notification filed by Medtox Diagnostics, Inc. with the FDA for Verdict -ii Tca, Verdict-ii Mtd.

Pre-market Notification Details

Device IDK011545
510k NumberK011545
Device Name:VERDICT -II TCA, VERDICT-II MTD
ClassificationRadioimmunoassay, Tricyclic Antidepressant Drugs
Applicant MEDTOX DIAGNOSTICS, INC. 1238 ANTHONY RD. Burlington,  NC  27215
ContactMichael Turanchik
CorrespondentMichael Turanchik
MEDTOX DIAGNOSTICS, INC. 1238 ANTHONY RD. Burlington,  NC  27215
Product CodeLFG  
CFR Regulation Number862.3910 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2001-05-18
Decision Date2001-06-08

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.